Data as of Jan 26
| +0.69 / +1.36%|
The 3 analysts offering 12-month price forecasts for West Pharmaceutical Services Inc have a median target of 53.00, with a high estimate of 57.00 and a low estimate of 48.00. The median estimate represents a +3.13% increase from the last price of 51.39.
The current consensus among 3 polled investment analysts is to Buy stock in West Pharmaceutical Services Inc. This rating has held steady since January, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.